IMPROVE MEDICAL INSTRUMENTS CO., LTD. Improve Medical Instruments Co., Ltd. Share Price
Equities
300030
CNE100000JL3
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.47 CNY | +0.68% |
|
-1.54% | -42.32% |
| Sales 2022 | 71Cr 9.82Cr 818.76Cr | Sales 2023 | 64Cr 8.9Cr 742.57Cr | Capitalization | 239.62Cr 33Cr 2.76TCr |
|---|---|---|---|---|---|
| Net income 2022 | -20Cr -2.73Cr -228.08Cr | Net income 2023 | -6.3Cr -87L -73Cr | EV / Sales 2022 | 3.28 x |
| Net Debt 2022 | 20Cr 2.79Cr 232.98Cr | Net Debt 2023 | 16Cr 2.25Cr 187.43Cr | EV / Sales 2023 | 3.97 x |
| P/E ratio 2022 |
-10.8
x | P/E ratio 2023 |
-38.8
x | Employees | 936 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 62.06% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.68% | ||
| 1 week | -1.54% | ||
| 1 month | -3.87% | ||
| 3 months | -12.87% | ||
| 6 months | -47.04% | ||
| Current year | -42.32% |
1 week
4.41
4.60
1 month
4.415.35
Current year
3.447.97
1 year
3.448.63
3 years
3.4413.39
5 years
3.4416.63
10 years
3.4438.00
| Managers | Title | Age | Since |
|---|---|---|---|
Guan Hua Deng
CEO | Chief Executive Officer | 58 | 26/07/26 |
Hong Yu Yan
DFI | Director of Finance/CFO | 60 | 22/10/22 |
Wei Yu
BRD | Director/Board Member | 38 | 31/21/31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 56 | 12/17/12 | |
Guan Hua Deng
CEO | Chief Executive Officer | 58 | 26/07/26 |
Hong Yu Yan
DFI | Director of Finance/CFO | 60 | 22/10/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/24/31 | 4.47 | +0.68% | 3,818,243 |
| 30/24/30 | 4.44 | -0.89% | 5,272,441 |
| 29/24/29 | 4.48 | -0.67% | 4,112,100 |
| 28/24/28 | 4.51 | -1.10% | 4,722,700 |
| 27/24/27 | 4.56 | +0.44% | 5,423,300 |
End-of-day quote Shenzhen S.E., May 31, 2024
More quotes
Improve Medical Instruments Co Ltd, formerly Guangzhou Improve Medical Instruments Co Ltd, is a China-based company mainly engaged in the production and sales of medical equipment. The Company is also engaged in the financial leasing business of medical equipment. The Company's products include vacuum blood collection systems, liquid biopsy tubes, automatic blood collection tube detachers, thromboelastometers and reagents, hospital intelligent blood collection management systems, sub-medical record systems (EMR) and others. The Company's products also include masks, instruments, reagents and others. The Company's products are exported to Russia, Saudi Arabia, Brazil, South Korea and other countries and regions.
Calendar
16/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -42.32% | 19Cr | |
| +7.01% | 22TCr | |
| +11.01% | 19TCr | |
| +19.20% | 14TCr | |
| +30.79% | 11TCr | |
| +1.48% | 6.46TCr | |
| +13.95% | 5.24TCr | |
| -0.16% | 4.85TCr | |
| -6.20% | 3.8TCr | |
| +0.91% | 3.56TCr |
- Stock Market
- Equities
- 300030 Stock
